Avamys, Nasenspray, Suspension
7680579680051
CH-57968
Nasenspray
Associated product:
AVAMYS spray nasal 27.5 mcg/dose 120 dos
1 / 3
google
Article details
- Package size
- 120
- Selling units
- 120
- Measure
- Einzeldose(n)
- Galenic form
- Nasenspray
- Galenic group
- Nasenmittel
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
27.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
8.25 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 18.45
Specialties list
Yes
Generic
No
SL addition date:
01/04/2008
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 57968
- Drug name
- Avamys, Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD12
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 19/12/2007
- Authorization expiration date
- 31/12/9999
- IT Number
- 12.02.3.
- Domain
- Human medicine
Package details
- Description (FR)
- AVAMYS spray nasal 27.5 mcg/dose 120 dos
- Description (DE)
- AVAMYS Nasenspray 27.5 mcg/Dosis 120 Dos
- Market launch
- 19/12/2007
- Narcotic (BTM)
- No
Available generics (1)
Fluticason-Mepha, Nasenspray, Suspension
GTIN: 7680693120013
CHF 16.70